Found 8 matching trials
Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Subjects PHASE1 This study is to compare PK, PD, safety, tolerability, and immunogenicity p...
Show More Learn More & Join Trial
Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND PHASE3 This is a randomized, double-blind, parallel design, repeat dose, 2 arm, mu...
Show More Location
Investigational Site 3501
Learn More & Join Trial
A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva PHASE1 Randomized, double blind, parallel group, single dose, 3 arm study to inves...
Show More Location
Biokinetica - Early Phase Institute
Learn More & Join Trial
Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects PHASE1 Part I of the study: This is a randomised, single-dose, subcutaneous inject...
Show More Location
Huashan Hospital,Fudan University
Learn More & Join Trial
A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis PHASE3 The primary objective of this study is to demonstrate equivalent efficacy o...
Show More Location
Diagnostic Consultative Center Aleksandrovska
Learn More & Join Trial
AVT03 With Xgeva in Healthy Male Subjects PHASE1 This study has been designed as a randomized, double-blind, parallel-group ...
Show More Learn More & Join Trial
Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® PHASE1 A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three-...
Show More Location
Xentria Investigative Site
Learn More & Join Trial
Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers PHASE1 This is a randomized, double-blind, three-arm, parallel-group, single-dose ...
Show More Learn More & Join Trial